Michael Shevell
ʰǴڱǰ
MDCM, FRCP, FCAHS

- MDCM 91, 1980-1984
- FRCP 91, 1984-1989
- Molecular & Medical Genetics Fellowship Medical Research Council of Canada, 1989-1991
Dr. Michael Shevell is an attending Pediatric Neurologist in the Division of Pediatric Neurology and a Professor (with tenure) in the Departments of Pediatrics & Neurology/Neurosurgery. From 2011-2021 Dr. Shevell was Chair of the Department of Pediatrics at 91 & Pediatrician-in-Chief of the Montreal Children’s Hospital. He has conducted clinical research focusing on the causes, care and consequences of children with neurodevelopmental disabilities and those biologically at risk for these disorders. Dr. Shevell has achieved high research productivity (h index 81, > 22000 citations, > 300 peer-reviewed papers, > 70 invited chapters/papers [October 2022]). Now in the twilight of his academic career, he is focusing his remaining efforts on analyses involving existing large clinically defined datasets (e.g., Canadian Cerebral Palsy Registry). Dr. Shevell restricts his supervision presently to Pediatric Neurology trainees and fellows and very select MDCM students.
- Neurodevelopmental disabilities (particularly cerebral palsy, intellectual developmental disorder/global developmental delay)
- Neonatal neurology
- Biologically at risk infants & children for neurodevelopmental sequelae
- Clinical research
- Neuroethics
- Neurodevelopmental disabilities (particularly cerebral palsy, intellectual developmental disorder/global developmental delay)
- Neonatal neurology
- Biologically at risk infants & children for neurodevelopmental sequelae
- Clinical research
- Neuroethics
- Inaugural Harvey Guyda Chair in Pediatrics-91, January 2012-July 2021
- Fellow of the Canadian Academy of Health Sciences (FCAHS), September 2014
- Hower Award-Child Neurology Society “The Hower Award is given annually to a person whom the Child Neurology Society deems has contributed greatly to the further understanding of neurological problems of childhood through research, teaching, clinical application, and leadership” (one of only 2 Canadians to receive this Award in 51 years), October 2014
- Pfizer Award for Research Excellence Montreal Children’s Hospital Foundation, May 2022
- Martha B. Denkla Award - Child Neurology Society “Career contributions to furthering our understanding of neurodevelopmental disabilities”, October 2022